8-K Announcements
6Material company update
Apr 9, 2026·SEC
Material company update
Mar 3, 2026·SEC
Material company update
Feb 24, 2026·SEC
Adtalem Global Education Inc.(ATGE)Earnings, Financials & Key Ratios
ATGE•NYSE
$106.64
17.6× P/E·Price updated Jun 20, 2026
SectorConsumer DefensiveIndustryEducation & TrainingSub-IndustryDegree-Granting Colleges and Universities
AboutAdtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.Show more
- Revenue$1.79B+12.9%
- EBITDA$393M+34.6%
- Net Income$237M+73.3%
- EPS (Diluted)6.07+79.1%
- Gross Margin56.86%+1.7%
- EBITDA Margin22%+19.3%
- Operating Margin19.1%+39.4%
- Net Margin13.26%+53.6%
- ROE16.92%+74.8%
ATGE Price & Volume
Adtalem Global Education Inc. (ATGE) stock price & volume — 10-year historical chart
Loading chart...
Specialized Healthcare Education Drives Margin Expansion Trends
Investment Thesis • Updated 2026Q2
VerdictNeutral
Growth:Accelerating
Profitability:Strong
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Regulatory and clinical capacity
Key Thesis Takeaways
- Adtalem is successfully scaling its specialized healthcare education programs, evidenced by a 12.4% year-over-year revenue growth to $503.4 million in 2026Q2.
- While operating margins have expanded significantly to 22.1% through operational leverage, investors should monitor the inherent volatility in cash flow conversion and potential regulatory risks to program sustainability.
- The company's disciplined capital allocation, including a $164.8 million buyback in 2026Q2, suggests management confidence, though the reliance on goodwill and seasonal working capital cycles warrants continued scrutiny.
Verdict Logic
while the forward P/E of 13.44 suggests reasonable valuation, the extreme volatility in operating cash flow to net income ratios, which ranged from -0.25 to 8.39, necessitates a cautious approach.
ATGE Growth Metrics
Adtalem Global Education Inc. (ATGE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-0.66%
5 Years15.6%
3 Years8.97%
TTM11.92%
Profit CAGR
10 Years5.42%
5 Years-
3 Years-8.65%
TTM21.6%
EPS CAGR
10 Years10.99%
5 Years6.17%
3 Years-
TTM25.51%
Return on Capital
10 Years7.19%
5 Years7.83%
3 Years10.43%
Last Year15.19%
ATGE Recent Earnings
Adtalem Global Education Inc. (ATGE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 10/12 qtrs (83%)
Q1 2026Latest
Jan 28, 2026Metric
Actual
Est
EPS
$2.43+11.0%
$2.19
Rev
$503M+3.0%
$489M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$1.75+11.5%
$1.57
Rev
$462M-5.4%
$489M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$1.66+9.9%
$1.51
Rev
$457M+3.3%
$442M
Q2 2025
May 8, 2025Metric
Actual
Est
EPS
$1.92+17.8%
$1.63
Rev
$466M+6.0%
$440M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Jan 28, 2026 | $2.43vs $2.19+11.0% | $503Mvs $489M+3.0% |
| Q4 2025 | Oct 30, 2025 | $1.75vs $1.57+11.5% | $462Mvs $489M-5.4% |
| Q3 2025 | Aug 7, 2025 | $1.66vs $1.51+9.9% | $457Mvs $442M+3.3% |
| Q2 2025 | May 8, 2025 | $1.92vs $1.63+17.8% | $466Mvs $440M+6.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Adtalem Global Education Inc. (ATGE)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $106.64 | $3.7B | 17.57 | 12.85% | 13.26% | 16.92% | — | |
| $35.16 | $2.2B | 14.53 | 24.2% | 19.91% | 17.21% | — | |
| $39.86 | $5.69B | 21.09 | 8.64% | 16.08% | 25.36% | — | |
| $1155.24 | $5.02B | 17.38 | 2.52% | 7.94% | 6.39% | — | |
| $79.19 | $1.8B | 14.61 | 3.96% | 10.21% | 7.85% | — | |
| $51.20 | $2.82B | 45.31 | 14.05% | 4.91% | 13.02% | — |
Compare ATGE vs Peers
Adtalem Global Education Inc. (ATGE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ATGE SEC Filings & Documents
Adtalem Global Education Inc. (ATGE) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when ATGE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ATGE Frequently Asked Questions
Adtalem Global Education Inc. (ATGE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Adtalem Global Education Inc.'s revenue?
Adtalem Global Education Inc. (ATGE) reported $1.89B in revenue for fiscal year 2025. This represents a 630% increase from $258.9M in 1996.
How fast is Adtalem Global Education Inc. growing?
Adtalem Global Education Inc. (ATGE) grew revenue by 12.9% over the past year. This is steady growth.
Is ATGE profitable?
Yes, Adtalem Global Education Inc. (ATGE) is profitable, generating $253.3M in net income for fiscal year 2025 (13.3% net margin).
Dividend & Returns
What is ATGE's return on equity?
Adtalem Global Education Inc. (ATGE) has a return on equity (ROE) of 16.9%. This is reasonable for most industries.
What is Adtalem Global Education Inc.'s free cash flow?
Adtalem Global Education Inc. (ATGE) generated $368.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.